-

Asset Value Investors (AVI) Submits Shareholder Proposals to NS Solutions, a Subsidiary of Nippon Steel

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) launched a public campaign on the submission of its shareholder proposals to NS Solutions (TYO 2327, “NSSOL”), a subsidiary of Nippon Steel Corporation (TYO 5401, “Nippon Steel”).

AVI owns 1.2% of voting rights of NSSOL. Having first invested in March 2020, the team has now concluded that a continued approach of constructive private dialogue has no prospects of success.

A detailed presentation has been published on AVI’s dedicated website - www.takingNSSOLtothenextlevel.com

AVI identified the following issues:

  • Due to the parent-subsidiary listing relationship between NSSOL and Nippon Steel, the standards of governance and treatment of minority shareholders expected of a Prime Market listed company have not been achieved.
  • Two former Nippon Steel executives with no experience in the IT services industry have been appointed as internal directors of NSSOL in the last two years.
  • NSSOL has deposited 90.2 billion yen of cash with its parent company Nippon Steel at an interest rate of about 0.2%.
  • NSSOL holds 67.8 billion yen in shares of its clients, mainly Recruit HD.
  • There is potential disregard for employee welfare issues.
  • The parent company holds a prohibitively high 63.4% of the shares, preventing NSSOL from conducting share buybacks from general shareholders as a further reduction in the free float could violate the criteria for prime listing.

Joe Bauernfreund, CEO of AVI, comments: “NS Solutions must take steps to achieve the highest standards of corporate governance and capital discipline that a Prime Market publicly traded company should uphold, and to address its undervaluation.

“As the controlling shareholder, Nippon Steel has an obligation to ensure that NS Solutions is managed for the benefit of all stakeholders. Nippon Steel has the power to hold NSSOL’s board to account and call on NSSOL to address poor employee welfare and its discounted valuation."

Despite regular private dialogue, the Board of Directors of NSSOL have ignored AVI’s recommendations and failed to put forward remedial solutions.

- ENDS

Notes to editors

AVI is a London-based investment management company that has been investing in Japanese equities for more than 20 years. AVI was established in 1985 and has been investing in the equity markets for more than 35 years. AVI's investment team is committed to contributing to sustainable improvements in corporate value by engaging with the management teams of its portfolio companies, with approximately ¥78bn invested in Japanese equities.

Asset Value Investors


Release Versions

More News From Asset Value Investors

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom